Market revenue in 2023 | USD 46.0 million |
Market revenue in 2030 | USD 71.5 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.43% in 2023. Horizon Databook has segmented the Chile clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
Rising number of clinical trials and CROs in the region is likely to boost the clinical trials supply and logistics market. The trend is expected to continue and is anticipated to attract players to this market, thereby contributing to growth of clinical trial supply and logistics market in the region.
Moreover, rising spread of coronavirus and growing investments by the government and private players for vaccine production are among factors likely to drive the market. For, instance, in August 2020, the government announced to support clinical trial headed by Sinovac and Universidad Católica, with a state contribution of around USD 3.4 million.
The country’s science and health officials announced that the protocol for conducting phase III clinical trials for COVID-19 vaccines in Chile began in the month of August 2020.
Horizon Databook provides a detailed overview of country-level data and insights on the Chile clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into Chile clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account